近日，央视新闻连续两次曝光渠道医美乱象。所谓"渠道医美"是指消费者不通过正常预约挂号到医疗美 容机构就诊，而是通过生活美容院员工、美甲师等中间人作为"介绍人 （渠道）"被带到特定医美机构 就医，医美机构将向介绍人支付高额返佣。 "如果用户感觉上述操作过于繁琐，还可以直接选择美团医美上拥有'北极星医美榜'标签的医美机 构。"美团相关业务负责人表示，"这份榜单结合行业权威专家和大众评审意见，2025年，全国仅有152 家医美机构和240位医生上榜，用户可放心选择。" 316 គាត 2 查医生 要求医生出示 《医师资格证书》《医师执业证书》 也可通过国家卫健委或 美团 查询 医生实名信息 & 医师执业订 celler 1163 5 正品验真 要求机构对所使用的产品和设备进行扫码验真 或直接选择 [美团]上拥有"放心美"标签的医美机构, 机构将主动对所使用的产品和设备进行验真 烟 美团·医美 - 才欣 小美 仍觉得流程繁琐? 士服呈医美I 直接选择 美团 拥有北极星医美榜 标签的医美机构 放心享受变美体验 这种高返佣模式的根源在于信息不透明、不对称，其背后隐藏着诸多问题和隐患。有行业人士表示，渠 道医美返佣比例畸高 ...

Core Insights - The article highlights the issues and risks associated with the "channel medical beauty" model, where medical beauty institutions rely on intermediaries for customer acquisition, often leading to high commission fees and potential misrepresentation of services [1][28]. Group 1: Company Operations - Shenzhen Jiexika Medical Health Industry Group is actively recruiting agents nationwide, with over 200 branches established across 27 provinces [1]. - The company claims an annual revenue of approximately 10 to 20 billion [1]. - The channel manager indicates that the commission rate for intermediaries typically ranges from 50% to 55% for outstanding performance [2]. Group 2: Product Claims and Legal Issues - Jiexika promotes a high-end project called "Slimming Health," claiming a 70% repurchase rate and exclusive rights to the "NCGCF Cell Regulation Factor" technology [2]. - Investigations reveal that the patents related to "NCGCF" are either expired or were rejected, indicating that the claims of exclusive patent ownership are misleading [3][5]. - Legal experts assert that the company's marketing practices constitute false advertising and unfair competition under Chinese law [5]. Group 3: Marketing Practices and Consumer Experience - The article describes a trend of excessive marketing and service imbalance in channel medical beauty, where institutions prioritize short-term profits over quality service [26][28]. - In Wuhan's "Yue Ta" medical beauty clinic, male consultants are employed to attract female customers, and there are reports of unqualified personnel performing procedures without proper medical oversight [6][9]. - Membership systems are in place, with consumers expressing regret over high membership fees, indicating potential traps in the marketing strategy [11]. Group 4: Regulatory Environment and Recommendations - Experts emphasize the need for a regulatory framework specific to the medical beauty industry to address the lack of standards and oversight [29][30]. - Recommendations include implementing a "挂牌亮证" (displaying qualifications) system to verify the credentials of medical beauty consultants and enhancing regulatory enforcement against false advertising and excessive commissions [30][32]. - The article concludes that the medical beauty industry should prioritize safety and quality over profit-driven motives to ensure consumer trust and industry integrity [32].